This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 Apr 18;346(16):1221-31.

doi: 10.1056/NEJMra011775.

Nonalcoholic fatty liver disease

Affiliations

PMID: 11961152
DOI: 10.1056/NEJMra011775

Review

Nonalcoholic fatty liver disease

Paul Angulo. N Engl J Med. 2002.

. 2002 Apr 18;346(16):1221-31.

doi: 10.1056/NEJMra011775.

Author

Affiliation

¹ Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minn 55905, USA. angulohernandez.paul@mayo.edu

PMID: 11961152
DOI: 10.1056/NEJMra011775

No abstract available

PubMed Disclaimer

Comment in

Nonalcoholic fatty liver disease.
Bode JC. Bode JC. N Engl J Med. 2002 Sep 5;347(10):768-9; author reply 768-9. doi: 10.1056/NEJM200209053471018. N Engl J Med. 2002. PMID: 12213955 No abstract available.
Nonalcoholic fatty liver disease.
Inzucchi SE, Petersen KF, Shulman GI. Inzucchi SE, et al. N Engl J Med. 2002 Sep 5;347(10):768-9; author reply 768-9. N Engl J Med. 2002. PMID: 12214631 No abstract available.
Nonalcoholic fatty liver disease.
Babb RR. Babb RR. N Engl J Med. 2002 Sep 5;347(10):768-9; author reply 768-9. N Engl J Med. 2002. PMID: 12214632 No abstract available.
Nonalcoholic fatty liver disease.
Marignani M, Angeletti S. Marignani M, et al. N Engl J Med. 2002 Sep 5;347(10):768-9; author reply 768-9. N Engl J Med. 2002. PMID: 12214633 No abstract available.

Similar articles

Nonalcoholic fatty liver disease: diagnosis and management.
Wilkins T, Tadkod A, Hepburn I, Schade RR. Wilkins T, et al. Am Fam Physician. 2013 Jul 1;88(1):35-42. Am Fam Physician. 2013. PMID: 23939604
Nonalcoholic fatty liver disease.
Adams LA, Angulo P, Lindor KD. Adams LA, et al. CMAJ. 2005 Mar 29;172(7):899-905. doi: 10.1503/cmaj.045232. CMAJ. 2005. PMID: 15795412 Free PMC article. Review.
Nonalcoholic fatty liver disease: is all the fat bad?
Clouston AD, Powell EE. Clouston AD, et al. Intern Med J. 2004 Apr;34(4):187-91. doi: 10.1111/j.1444-0903.2004.00574.x. Intern Med J. 2004. PMID: 15086699 Review.
AGA technical review on nonalcoholic fatty liver disease.
Sanyal AJ; American Gastroenterological Association. Sanyal AJ, et al. Gastroenterology. 2002 Nov;123(5):1705-25. doi: 10.1053/gast.2002.36572. Gastroenterology. 2002. PMID: 12404245 Review. No abstract available.
[Nonalcoholic fatty liver].
Dancygier H. Dancygier H. Versicherungsmedizin. 2002 Mar 1;54(1):11-5. Versicherungsmedizin. 2002. PMID: 11933860 German.

See all similar articles

Cited by

Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis.
Starmann J, Fälth M, Spindelböck W, Lanz KL, Lackner C, Zatloukal K, Trauner M, Sültmann H. Starmann J, et al. PLoS One. 2012;7(10):e46584. doi: 10.1371/journal.pone.0046584. Epub 2012 Oct 10. PLoS One. 2012. PMID: 23071592 Free PMC article.
O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease.
Zhou Y, Li Z, Xu M, Zhang D, Ling J, Yu P, Shen Y. Zhou Y, et al. Cells. 2022 Nov 16;11(22):3637. doi: 10.3390/cells11223637. Cells. 2022. PMID: 36429065 Free PMC article. Review.
Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction.
Lonardo A, Singal AK, Osna N, Kharbanda KK. Lonardo A, et al. Metab Target Organ Damage. 2022;2(3):12. doi: 10.20517/mtod.2022.14. Epub 2022 Aug 22. Metab Target Organ Damage. 2022. PMID: 36090199 Free PMC article.
The role of oxidized lipid species in insulin resistance and NASH in children.
Santoro N, Feldstein AE. Santoro N, et al. Front Endocrinol (Lausanne). 2022 Oct 3;13:1019204. doi: 10.3389/fendo.2022.1019204. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36263326 Free PMC article. Review.
Cholecystectomy does not significantly increase the risk of fatty liver disease.
Wang HG, Wang LZ, Fu HJ, Shen P, Huang XD, Zhang FM, Xie R, Yang XZ, Ji GZ. Wang HG, et al. World J Gastroenterol. 2015 Mar 28;21(12):3614-8. doi: 10.3748/wjg.v21.i12.3614. World J Gastroenterol. 2015. PMID: 25834328 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database